ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 137 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 8.14 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $566,000 | +62.2% | 30,017 | +17.3% | 0.01% | +25.0% |
| Q1 2019 | $349,000 | -12.5% | 25,596 | -34.3% | 0.00% | -20.0% |
| Q4 2018 | $399,000 | -46.4% | 38,953 | -12.9% | 0.01% | -44.4% |
| Q3 2018 | $745,000 | +97.1% | 44,735 | +86.7% | 0.01% | +80.0% |
| Q2 2018 | $378,000 | -80.9% | 23,955 | -84.6% | 0.01% | -83.9% |
| Q1 2018 | $1,978,000 | +451.0% | 155,711 | +396.6% | 0.03% | +416.7% |
| Q4 2017 | $359,000 | -21.8% | 31,358 | +125.6% | 0.01% | -88.0% |
| Q4 2015 | $459,000 | +37.4% | 13,900 | +120.6% | 0.05% | -53.7% |
| Q2 2015 | $334,000 | – | 6,300 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $40,160,000 | 10.45% |
| Foresite Capital Management II, LLC | 1,586,220 | $21,652,000 | 9.78% |
| DAFNA Capital Management LLC | 571,013 | $7,794,000 | 3.36% |
| Redmile Group, LLC | 8,244,896 | $112,543,000 | 3.29% |
| Lion Point Capital, LP | 1,271,500 | $17,355,000 | 1.57% |
| Palo Alto Investors LP | 1,861,630 | $25,411,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,185,983 | $43,488,000 | 1.03% |
| Bellevue Group AG | 1,286,748 | $17,564,000 | 0.97% |
| BB BIOTECH AG | 2,766,008 | $37,756,000 | 0.95% |
| Rock Springs Capital Management LP | 1,560,000 | $21,294,000 | 0.82% |